$ULBI
ULTRALIFE CORP

2024 Q3 Form 10-Q Financial Statement

#000143774924023416 Filed on July 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $35.69M $42.98M
YoY Change -9.61% 0.68%
Cost Of Revenue $27.01M $31.42M
YoY Change -9.09% -2.13%
Gross Profit $8.682M $11.56M
YoY Change -11.17% 9.21%
Gross Profit Margin 24.32% 26.9%
Selling, General & Admin $6.070M $5.649M
YoY Change 5.2% 14.31%
% of Gross Profit 69.91% 48.85%
Research & Development $2.101M $1.997M
YoY Change 12.41% 13.85%
% of Gross Profit 24.2% 17.27%
Depreciation & Amortization $765.0K $789.0K
YoY Change 0.66% -20.06%
% of Gross Profit 8.81% 6.82%
Operating Expenses $8.171M $7.646M
YoY Change 6.96% 10.44%
Operating Profit $511.0K $3.917M
YoY Change -76.07% 6.88%
Interest Expense -$173.0K -$418.0K
YoY Change -70.68% -5.0%
% of Operating Profit -33.86% -10.67%
Other Income/Expense, Net -$158.0K -$71.00K
YoY Change -59.07% -104.74%
Pretax Income $353.0K $3.846M
YoY Change -79.82% -18.57%
Income Tax $74.00K $853.0K
% Of Pretax Income 20.96% 22.18%
Net Earnings $258.0K $2.969M
YoY Change -80.6% -11.11%
Net Earnings / Revenue 0.72% 6.91%
Basic Earnings Per Share $0.02 $0.21
Diluted Earnings Per Share $0.02 $0.21
COMMON SHARES
Basic Shares Outstanding 16.62M 16.47M
Diluted Shares Outstanding 16.87M 16.83M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.774M $6.690M
YoY Change -26.37% -18.43%
Cash & Equivalents $6.774M $6.690M
Short-Term Investments
Other Short-Term Assets $7.908M $4.650M
YoY Change 21.66% -5.7%
Inventory $43.99M $41.39M
Prepaid Expenses
Receivables $27.75M $31.06M
Other Receivables $0.00 $0.00
Total Short-Term Assets $86.43M $83.79M
YoY Change -3.49% -4.6%
LONG-TERM ASSETS
Property, Plant & Equipment $20.25M $20.28M
YoY Change -4.35% -12.99%
Goodwill $37.79M $37.51M
YoY Change 1.16% 0.02%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.361M $4.505M
YoY Change 114.3% -59.79%
Total Long-Term Assets $86.01M $86.03M
YoY Change -0.63% -1.75%
TOTAL ASSETS
Total Short-Term Assets $86.43M $83.79M
Total Long-Term Assets $86.01M $86.03M
Total Assets $172.4M $169.8M
YoY Change -2.08% -3.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.68M $9.691M
YoY Change -5.86% -47.73%
Accrued Expenses $11.52M $8.882M
YoY Change 5.72% 2.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $2.000M
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $26.20M $20.57M
YoY Change -0.69% -29.55%
LONG-TERM LIABILITIES
Long-Term Debt $5.888M $9.978M
YoY Change -75.58% -55.93%
Other Long-Term Liabilities $4.093M $4.279M
YoY Change 101.43% 114.38%
Total Long-Term Liabilities $9.981M $14.26M
YoY Change -61.82% -42.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.20M $20.57M
Total Long-Term Liabilities $9.981M $14.26M
Total Liabilities $37.81M $36.47M
YoY Change -30.43% -34.71%
SHAREHOLDERS EQUITY
Retained Earnings -$34.64M -$34.89M
YoY Change -20.61% -22.38%
Common Stock $2.106M $2.106M
YoY Change 1.49% 2.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $134.5M $133.2M
YoY Change
Total Liabilities & Shareholders Equity $172.4M $169.8M
YoY Change -2.08% -3.18%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $258.0K $2.969M
YoY Change -80.6% -11.11%
Depreciation, Depletion And Amortization $765.0K $789.0K
YoY Change 0.66% -20.06%
Cash From Operating Activities $4.746M $8.925M
YoY Change -633.26% 409.71%
INVESTING ACTIVITIES
Capital Expenditures $594.0K $360.0K
YoY Change 10.0% -30.23%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$594.0K -$360.0K
YoY Change 10.0% -30.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.077M -11.93M
YoY Change -267.78% -863.64%
NET CHANGE
Cash From Operating Activities 4.746M 8.925M
Cash From Investing Activities -594.0K -360.0K
Cash From Financing Activities -4.077M -11.93M
Net Change In Cash 75.00K -3.363M
YoY Change -92.5% -220.24%
FREE CASH FLOW
Cash From Operating Activities $4.746M $8.925M
Capital Expenditures $594.0K $360.0K
Free Cash Flow $4.152M $8.565M
YoY Change -390.35% 593.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
125332000 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
132000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
133345000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
31420000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
11563000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1997000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5649000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3917000 usd
CY2024Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
418000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1498000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1058000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4723000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1375000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-888000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
19000 usd
us-gaap Net Income Loss
NetIncomeLoss
2994000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Cash
Cash
10278000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
90203000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21117000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
37571000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3711000 usd
CY2023Q4 us-gaap Assets
Assets
178276000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9691000 usd
us-gaap Gross Profit
GrossProfit
18024000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3810000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10523000 usd
us-gaap Operating Expenses
OperatingExpenses
15053000 usd
us-gaap Operating Expenses
OperatingExpenses
14333000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
7980000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3691000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
938000 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
864000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
411000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1428000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-527000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
564000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7453000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4255000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3047000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5625000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2898000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16568000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16141000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16482000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16138000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16825000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16144000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16661000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16141000
us-gaap Profit Loss
ProfitLoss
5897000 usd
us-gaap Profit Loss
ProfitLoss
3013000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.1
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11336000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3115000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7279000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23730000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23624000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1714000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3781000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
52849000 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
116404000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
3348000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
62000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
153000 usd
CY2023Q2 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
1000 usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20281000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
37510000 usd
CY2024Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
14646000 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
15107000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9088000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10567000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4505000 usd
CY2024Q2 us-gaap Assets
Assets
169817000 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4436114
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
21492000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42692000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
84910000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
32104000 usd
us-gaap Cost Of Revenue
CostOfRevenue
61877000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
10588000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11300000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
7646000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
6923000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3665000 usd
CY2023Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
440000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
347000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-71000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3846000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
853000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1556000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
2993000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
3348000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
24000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
37000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
2969000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3340000 usd
us-gaap Net Income Loss
NetIncomeLoss
5860000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2966000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3362000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-165000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2570000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10278000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6690000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8283000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
116403000 usd
us-gaap Profit Loss
ProfitLoss
3013000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
62000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
291000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.1
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
296000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
300000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31055000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31761000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
41392000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4650000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5949000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
83787000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2312000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6570000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
20573000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9978000 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1642000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4279000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
36472000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21059461
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20783607
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16623347
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16347493
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34894000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40754000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3895000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3660000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
133213000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
95000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
125427000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
169817000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178276000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42983000 usd
us-gaap Profit Loss
ProfitLoss
5897000 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000875657
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2024Q2 us-gaap Cash
Cash
6690000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
42215000 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
2106000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2078000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
191388000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
189160000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4436114
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
21492000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
74608000 usd
us-gaap Cost Of Revenue
CostOfRevenue
56584000 usd
us-gaap Gross Profit
GrossProfit
23033000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1778000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3753000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5145000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1242000 usd
us-gaap Profit Loss
ProfitLoss
3013000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-293000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-235000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-96000 usd
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
257000
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
179000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000
us-gaap Depreciation
Depreciation
1529000 usd
us-gaap Depreciation
Depreciation
1522000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
455000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
436000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
32000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
32000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
320000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
293000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1394000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-654000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
803000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-717000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4882000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-404000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
526000 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-2558000 usd
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
413000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8844000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
386000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
732000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1013000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-732000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1013000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1936000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
62000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11743000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3588000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5713000 usd
ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
2000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-96000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
119675000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
125427000 usd
us-gaap Profit Loss
ProfitLoss
5897000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1936000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
308000 usd
ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
12000 usd
us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-235000 usd
CY2023Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-293000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
128945000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
2993000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1251000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
152000 usd
CY2024Q2 ulbi Adjustments To Additional Paid In Capital Sharebased Compensation Restricted Stock Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRestrictedStockRequisiteServicePeriodRecognition
7000 usd
CY2024Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-3000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
133345000 usd
CY2024Q2 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
873898
CY2024Q2 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
5229
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
257068
CY2023Q2 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
4166
CY2023Q2 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
2500
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2334
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
795898
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
5229
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
179112
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
2500
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2157
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6690000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10196000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
82000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6690000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10278000 usd
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29848000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
29098000 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3185000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3187000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8359000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9930000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
41392000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
42215000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
87302000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
87601000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
67021000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
66484000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20281000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21117000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
789000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
760000 usd
us-gaap Depreciation
Depreciation
1529000 usd
us-gaap Depreciation
Depreciation
1522000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
37571000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-61000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
37510000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28236000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13590000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14646000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28247000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13140000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15107000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
227000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
227000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
455000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
436000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
159000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
154000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
320000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
293000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1250595
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3460
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.84
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
288675
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
91482
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.79
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
873898
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.92
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M2D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3231000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
775281
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
7
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y2M4D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
2805000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
417867
CY2024Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
7.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y10M13D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1277000 usd
CY2024Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1251000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
62000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1936000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
62000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.292 pure
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
268000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
239000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
530000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
480000 usd
CY2024Q2 us-gaap Variable Lease Cost
VariableLeaseCost
24000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
29000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
52000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
57000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
292000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
268000 usd
us-gaap Lease Cost
LeaseCost
582000 usd
us-gaap Lease Cost
LeaseCost
537000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
568000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
494000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1391000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
310000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.068 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
539000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1016000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
942000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
969000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
977000 usd
CY2024Q2 ulbi Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
624000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5067000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
765000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
547000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
323000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
389000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
172000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
147000 usd
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
62000 usd
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
789000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
433000 usd
CY2024Q2 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
1264000 usd
CY2023Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
1407000 usd
CY2024Q2 us-gaap Revenues
Revenues
42983000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3917000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-71000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
853000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
24000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
2969000 usd
CY2023Q2 us-gaap Revenues
Revenues
42692000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3665000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1058000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1375000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3340000 usd
us-gaap Revenues
Revenues
84910000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
7980000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-527000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1556000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
37000 usd
us-gaap Net Income Loss
NetIncomeLoss
5860000 usd
us-gaap Revenues
Revenues
74608000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3691000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
564000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1242000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
19000 usd
us-gaap Net Income Loss
NetIncomeLoss
2994000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42983000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42692000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
84910000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
74608000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42983000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42692000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
84910000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
74608000 usd

Files In Submission

Name View Source Status
0001437749-24-023416-index-headers.html Edgar Link pending
0001437749-24-023416-index.html Edgar Link pending
0001437749-24-023416.txt Edgar Link pending
0001437749-24-023416-xbrl.zip Edgar Link pending
ex_700938.htm Edgar Link pending
ex_700939.htm Edgar Link pending
ex_700940.htm Edgar Link pending
ex_701938.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ulbi-20240630.xsd Edgar Link pending
ulbi20240630_10q.htm Edgar Link pending
ulbi-20240630_pre.xml Edgar Link unprocessable
ulbi20240630_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
ulbi-20240630_def.xml Edgar Link unprocessable
ulbi-20240630_cal.xml Edgar Link unprocessable
ulbi-20240630_lab.xml Edgar Link unprocessable